During high-fat diet feeding, EPO treatment increases hematocrit and also exhibits an anti-obesity effect in these female mice, decreasing fat mass accumulation and increasing brown fat-associated gene expression in WAT [58]. Here, EPO is linked to obesity due to melanocortin 4 receptor deficiency.